Shares of Inspire Medical Systems (NASDAQ:INSP) have earned a consensus rating of “Buy” from the six research firms that are covering the stock, Marketbeat reports. Three analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 12 month target price among brokerages that have covered the stock in the last year is $36.20.

A number of equities analysts recently commented on the stock. Zacks Investment Research downgraded shares of Inspire Medical Systems from a “buy” rating to a “hold” rating in a research note on Thursday, August 9th. Bank of America assumed coverage on shares of Inspire Medical Systems in a research note on Tuesday, May 29th. They issued a “neutral” rating and a $36.00 price objective for the company. Goldman Sachs Group assumed coverage on shares of Inspire Medical Systems in a research note on Tuesday, May 29th. They issued a “neutral” rating and a $25.00 price objective for the company. Guggenheim assumed coverage on shares of Inspire Medical Systems in a research note on Tuesday, May 29th. They issued a “buy” rating and a $40.00 price objective for the company. Finally, Stifel Nicolaus assumed coverage on shares of Inspire Medical Systems in a research note on Tuesday, May 29th. They issued a “buy” rating and a $42.00 price objective for the company.

NASDAQ:INSP traded down $1.22 during trading hours on Thursday, reaching $42.73. The company’s stock had a trading volume of 335,874 shares, compared to its average volume of 198,931. Inspire Medical Systems has a 12 month low of $22.50 and a 12 month high of $57.87.

Inspire Medical Systems (NASDAQ:INSP) last issued its quarterly earnings data on Tuesday, August 7th. The company reported ($0.43) EPS for the quarter, topping analysts’ consensus estimates of ($0.51) by $0.08. The business had revenue of $10.94 million during the quarter, compared to the consensus estimate of $9.30 million.

Several hedge funds have recently modified their holdings of the company. Northern Trust Corp acquired a new position in shares of Inspire Medical Systems during the second quarter worth $3,373,000. Bank of New York Mellon Corp acquired a new position in shares of Inspire Medical Systems during the second quarter worth $1,902,000. Millennium Management LLC acquired a new position in shares of Inspire Medical Systems during the second quarter worth $26,752,000. Orbimed Advisors LLC acquired a new position in shares of Inspire Medical Systems during the second quarter worth $87,161,000. Finally, Redmile Group LLC acquired a new position in shares of Inspire Medical Systems during the second quarter worth $7,132,000.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

Further Reading: Stock Symbols and CUSIP Explained

Analyst Recommendations for Inspire Medical Systems (NASDAQ:INSP)

Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.